Avantor, Inc. (NYSE:AVTR – Get Free Report) saw a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 34,740,000 shares, an increase of 25.0% from the May 15th total of 27,800,000 shares. Currently, 5.2% of the company’s stock are short sold. Based on an average daily trading volume, of 11,960,000 shares, the short-interest ratio is currently 2.9 days.
Insider Buying and Selling at Avantor
In other news, Director Joseph R. Massaro purchased 8,100 shares of the company’s stock in a transaction on Tuesday, April 29th. The shares were bought at an average price of $12.30 per share, for a total transaction of $99,630.00. Following the completion of the purchase, the director now owns 35,038 shares of the company’s stock, valued at $430,967.40. This trade represents a 30.07% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gregory L. Summe purchased 25,000 shares of the company’s stock in a transaction on Wednesday, May 7th. The stock was purchased at an average price of $12.00 per share, for a total transaction of $300,000.00. Following the purchase, the director now directly owns 50,000 shares of the company’s stock, valued at $600,000. This trade represents a 100.00% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 83,100 shares of company stock valued at $1,027,630 in the last ninety days. Insiders own 1.20% of the company’s stock.
Institutional Investors Weigh In On Avantor
Several institutional investors and hedge funds have recently modified their holdings of the business. Stanley Capital Management LLC raised its holdings in Avantor by 42.9% in the 1st quarter. Stanley Capital Management LLC now owns 998,500 shares of the company’s stock worth $16,186,000 after acquiring an additional 300,000 shares during the period. Strs Ohio bought a new position in shares of Avantor during the 1st quarter worth about $8,105,000. Advisors Capital Management LLC increased its holdings in shares of Avantor by 16.3% during the 1st quarter. Advisors Capital Management LLC now owns 277,173 shares of the company’s stock worth $4,493,000 after purchasing an additional 38,942 shares during the period. Woodline Partners LP increased its holdings in shares of Avantor by 14.5% during the 1st quarter. Woodline Partners LP now owns 1,380,688 shares of the company’s stock worth $22,381,000 after purchasing an additional 174,361 shares during the period. Finally, Empowered Funds LLC increased its holdings in shares of Avantor by 40.3% during the 1st quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock worth $286,000 after purchasing an additional 5,075 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.
Wall Street Analysts Forecast Growth
View Our Latest Report on AVTR
Avantor Stock Up 1.2%
AVTR stock opened at $13.31 on Friday. The company has a current ratio of 1.12, a quick ratio of 0.75 and a debt-to-equity ratio of 0.54. Avantor has a 1 year low of $11.82 and a 1 year high of $28.00. The company has a fifty day simple moving average of $13.44 and a 200 day simple moving average of $17.23. The firm has a market cap of $9.07 billion, a PE ratio of 12.80, a PEG ratio of 1.33 and a beta of 1.04.
Avantor (NYSE:AVTR – Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $0.23 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.23. Avantor had a net margin of 10.70% and a return on equity of 11.93%. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.61 billion. During the same quarter in the previous year, the business earned $0.22 EPS. Avantor’s quarterly revenue was down 5.9% compared to the same quarter last year. Sell-side analysts anticipate that Avantor will post 1.06 EPS for the current fiscal year.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- 3 Healthcare Dividend Stocks to Buy
- Robinhood Director Sells Millions, But HOOD Stock Eyes Gains
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill
- Where to Find Earnings Call Transcripts
- Super Micro Computer Stock’s Rally Backed by Strong Financials
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.